{"id":"W4245051009","doi":"10.2165/00128413-200514740-00048","title":"Health Canada has approved bortezomib [Velcade; Millennium Pharmaceuticals].","year":2005,"lang":"en","type":"article","venue":"Inpharma Weekly","topic":"Healthcare Systems and Practices","field":"Health Professions","cited_by":0,"is_retracted":false,"has_abstract":false,"ca_institutions":"","funders":"","keywords":"Medicine; Bortezomib; Pharmacy; Pharmacology; Family medicine; Oncology; Internal medicine; Multiple myeloma","routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","sts","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.002869697,0.0003865474,0.0007408319,0.0001235541,0.001883538,0.00004051755,0.0004502408,0.0002782019,0.002613359],"category_scores_gemma":[0.0003558836,0.0003490497,0.00009496028,0.0003658478,0.00008067927,0.0003723143,0.000146054,0.002048163,0.001111065],"about_ca_system_candidate":true,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001283134,"about_ca_system_score_gemma":0.01027372,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.6518264,"about_ca_topic_score_gemma":0.7125484,"domain_scores_codex":[0.992837,0.002501648,0.001586074,0.0006188462,0.0007372068,0.001719297],"domain_scores_gemma":[0.9958621,0.001297605,0.000751787,0.0005606549,0.0002611109,0.001266756],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0001127665,0.00008256388,0.003583317,0.0006249676,0.00006373013,0.00002223861,0.002303543,0.000009665969,0.0002842056,0.0004890336,0.9382125,0.05421152],"study_design_scores_gemma":[0.001635103,0.00006178839,0.00369137,0.0001572974,0.00002033125,0.00001827491,0.002062452,0.0006452876,0.0001139688,0.00001072255,0.9912406,0.000342856],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","genre_codex":"commentary","genre_gemma":"empirical","genre_scores_codex":[0.04407544,0.01164467,0.0002201686,0.8805992,0.006378014,0.003200171,0.0003713814,0.0004656031,0.05304535],"genre_scores_gemma":[0.9073851,0.0009675244,0.0007338816,0.07760851,0.003595707,0.000275004,0.00004812172,0.00008865047,0.009297472],"genre_candidate":"commentary","genre_consensus":null,"teacher_disagreement_score":0.8633097,"threshold_uncertainty_score":0.9998962,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.2246281412208943,"score_gpt":0.51268809366099,"score_spread":0.2880599524400956,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}